Sinovac vaccine recipients more likely to develop severe COVID-19 than Pfizer: Study
A Singapore study has found that recipients of the Sinovac vaccine are nearly five times more likely to experience severe symptoms from COVID-19 than those who received Pfizer shots. The study involved about 2.7 million adults who received two doses under the national vaccination programme. CNA spoke to Dr Calvin Chiew, Associate Consultant at the National Public Health and Epidemiology Unit at NCID. He is one of the authors of the study.
Subscribe to our channel here: https://cna.asia/youtubesub
Subscribe to our news service on Telegram: https://cna.asia/telegram
Follow us:
CNA: https://cna.asia
CNA Lifestyle: http://www.cnalifestyle.com
Facebook: / channelnewsasia
Instagram: / channelnewsasia
Twitter: / channelnewsasia
Watch video Sinovac vaccine recipients more likely to develop severe COVID-19 than Pfizer: Study online without registration, duration hours minute second in high quality. This video was added by user CNA 14 April 2022, don't forget to share it with your friends and acquaintances, it has been viewed on our site 53,081 once and liked it 451 people.